Literature DB >> 10395799

Identification and characterization of AFG3L2, a novel paraplegin-related gene.

S Banfi1, M T Bassi, G Andolfi, A Marchitiello, S Zanotta, A Ballabio, G Casari, B Franco.   

Abstract

We recently identified a gene responsible for an autosomal recessive form of hereditary spastic paraplegia (HSP). This gene encodes paraplegin, a mitochondrial protein highly homologous to the yeast mitochondrial ATPases Afg3p and Rcalp, which have both proteolytic and chaperone-like activities at the inner mitochondrial membrane. By screening the Expressed Sequence Tag database, we identified and characterized a novel human cDNA, ATPase family gene 3-like 2 (AFG3L2, Human Gene Nomenclature Committee-approved symbol), which is closely related to paraplegin. This cDNA encodes a 797-amino-acid predicted protein highly similar to paraplegin as well as to yeast Afg3p and Rca1p. Immunofluorescence studies revealed that AFG3L2 and paraplegin share a similar expression pattern and the same subcellular localization, the mitochondrial compartment. We subsequently mapped AFG3L2 to chromosome 18p11 by radiation hybrid analysis. AFG3L2 may represent a candidate gene for other forms of HSPs and possibly for other neurodegenerative disorders. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395799     DOI: 10.1006/geno.1999.5818

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  26 in total

Review 1.  Hereditary spastic paraparesis: a review of new developments.

Authors:  C McDermott; K White; K Bushby; P Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

2.  Early onset and slow progression of SCA28, a rare dominant ataxia in a large four-generation family with a novel AFG3L2 mutation.

Authors:  Ulf Edener; Janine Wöllner; Ute Hehr; Zacharias Kohl; Stefan Schilling; Friedmar Kreuz; Peter Bauer; Veronica Bernard; Gabriele Gillessen-Kaesbach; Christine Zühlke
Journal:  Eur J Hum Genet       Date:  2010-03-31       Impact factor: 4.246

3.  Unique Structural Features of the Mitochondrial AAA+ Protease AFG3L2 Reveal the Molecular Basis for Activity in Health and Disease.

Authors:  Cristina Puchades; Bojian Ding; Albert Song; R Luke Wiseman; Gabriel C Lander; Steven E Glynn
Journal:  Mol Cell       Date:  2019-07-18       Impact factor: 17.970

4.  Neurocognitive Characterization of an SCA28 Family Caused by a Novel AFG3L2 Gene Mutation.

Authors:  Laszlo Szpisjak; Viola L Nemeth; Noemi Szepfalusi; Denes Zadori; Zoltan Maroti; Tibor Kalmar; Laszlo Vecsei; Peter Klivenyi
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

5.  Diphenylarsinic acid promotes degradation of glutaminase C by mitochondrial Lon protease.

Authors:  Kayoko Kita; Toshihide Suzuki; Takafumi Ochi
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

6.  Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy.

Authors:  Stephan Klebe; Christel Depienne; Sylvie Gerber; Georges Challe; Mathieu Anheim; Perrine Charles; Estelle Fedirko; Elodie Lejeune; Julien Cottineau; Alfredo Brusco; Hélène Dollfus; Patrick F Chinnery; Cecilia Mancini; Xavier Ferrer; Guilhem Sole; Alain Destée; Jean-Michel Mayer; Bertrand Fontaine; Jérôme de Seze; Michel Clanet; Elisabeth Ollagnon; Philippe Busson; Cécile Cazeneuve; Giovanni Stevanin; Josseline Kaplan; Jean-Michel Rozet; Alexis Brice; Alexandra Durr
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

7.  A novel missense mutation in AFG3L2 associated with late onset and slow progression of spinocerebellar ataxia type 28.

Authors:  Anna Mareike Löbbe; Jun-Suk Kang; Rüdiger Hilker; Holger Hackstein; Ulrich Müller; Dagmar Nolte
Journal:  J Mol Neurosci       Date:  2013-11-29       Impact factor: 3.444

Review 8.  Mitochondrial Quality Control Proteases in Neuronal Welfare.

Authors:  Roman M Levytskyy; Edward M Germany; Oleh Khalimonchuk
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-02       Impact factor: 4.147

9.  Mitochondrial ClpP activity is required for cisplatin resistance in human cells.

Authors:  Yang Zhang; Michael R Maurizi
Journal:  Biochim Biophys Acta       Date:  2015-12-07

10.  A novel frameshift mutation in the AFG3L2 gene in a patient with spinocerebellar ataxia.

Authors:  Zuzana Musova; Michaela Kaiserova; Eva Kriegova; Regina Fillerova; Peter Vasovcak; Alena Santava; Katerina Mensikova; Alena Zumrova; Anna Krepelova; Zdenek Sedlacek; Petr Kanovsky
Journal:  Cerebellum       Date:  2014-06       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.